CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $20.26 million. The enterprise value is $4.79 million.

Market Cap	20.26M
Enterprise Value	4.79M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 13.97 million shares outstanding. The number of shares has increased by 83.62% in one year.

Current Share Class	13.97M
Shares Outstanding	13.97M
Shares Change (YoY)	+83.62%
Shares Change (QoQ)	+8.96%
Owned by Insiders (%)	11.89%
Owned by Institutions (%)	14.03%
Float	5.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.84
P/TBV Ratio	1.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.66, with a Debt / Equity ratio of 0.79.

Current Ratio	5.66
Quick Ratio	5.52
Debt / Equity	0.79
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.17

Financial Efficiency

Return on equity (ROE) is -134.15% and return on invested capital (ROIC) is -84.84%.

Return on Equity (ROE)	-134.15%
Return on Assets (ROA)	-59.39%
Return on Invested Capital (ROIC)	-84.84%
Return on Capital Employed (ROCE)	-119.37%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.88% in the last 52 weeks. The beta is 1.35, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-68.88%
50-Day Moving Average	1.72
200-Day Moving Average	2.72
Relative Strength Index (RSI)	32.78
Average Volume (20 Days)	26,381

Short Selling Information

The latest short interest is 110,242, so 0.79% of the outstanding shares have been sold short.

Short Interest	110,242
Short Previous Month	112,961
Short % of Shares Out	0.79%
Short % of Float	1.91%
Short Ratio (days to cover)	5.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.93M
Pretax Income	-14.94M
Net Income	-18.87M
EBITDA	-24.88M
EBIT	-24.93M
Earnings Per Share (EPS)	-$1.53

Full Income Statement

Balance Sheet

The company has $24.63 million in cash and $8.60 million in debt, giving a net cash position of $16.03 million or $1.15 per share.

Cash & Cash Equivalents	24.63M
Total Debt	8.60M
Net Cash	16.03M
Net Cash Per Share	$1.15
Equity (Book Value)	10.89M
Book Value Per Share	0.78
Working Capital	20.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.31 million and capital expenditures -$17,000, giving a free cash flow of -$21.33 million.

Operating Cash Flow	-21.31M
Capital Expenditures	-17,000
Free Cash Flow	-21.33M
FCF Per Share	-$1.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-83.62%
Shareholder Yield	-83.62%
Earnings Yield	-90.65%
FCF Yield	-102.44%

Analyst Forecast

The average price target for CalciMedica is $16.33, which is 1,026.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.33
Price Target Difference	1,026.21%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a